To discuss Medicare Advantage & RADV Expansion, Revelare is co-hosting a call with Aldis Institutional Services, an independent policy research provider with a MAO Legal/Plan Expert.
CMS has taken a significant step forward in its efforts to intensify scrutiny of Medicare Advantage plans. Following the April 2023 Final Rule permitting extrapolation of RADV error rates, the May 21st announcement outlines a dramatic escalation in audit volume, staffing, and overpayment recovery—all signaling heightened compliance and financial risk for MA organizations.
To break down the implications of these sweeping changes, Aldis Institutional is pleased to host Elizabeth Lippincott, Managing Member of Strategic Health Law. Elizabeth brings extensive experience advising MA plans and health systems on regulatory compliance, managed care strategy, and federal investigations. She previously served as Associate General Counsel for a Fortune 100 healthcare company and is a trusted advisor on CMS and OIG-related audit strategy and defense.
Key Topics Include:
May 21 CMS RADV announcement and its implications for MA plans
Impact of scale-up in CMS audit activity: from 60 to 550 MA organizations per year
Significance of 5/30/25 HPMS Memo with deadlines for submission of risk adjustment data corrections for 2019 through 2024
Financial exposure risks and mitigation considerations